U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...
Vertex Pharmaceuticals (VRTX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Zacks.com on MSN1d
Alphabet's Q4 Earnings Loom: Buy or Sell GOOGL Stock Ahead of Results?Alphabet GOOGL is set to report fourth-quarter 2024 results on Feb. 4. Find the latest EPS estimates and surprises on Zacks ...
On Feb. 24, from west to east, you can see Mercury, Saturn, Neptune, Venus, Uranus, Jupiter and Mars, all spanning 117.5°, plus Earth under your feet—all eight known planets of our solar system!
British Watchmakers’ Day is held on Saturday 8 March 2025 at the Lindley Hall, London. There will be 2 sessions: 10am-2pm and 2pm-6pm. Free Club member tickets are now available to reserve for Club ...
U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its ...
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...
In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback